Pre-Open Stock Movers

FibroGen, Inc. (NASDAQ: FGEN) 36.2% LOWER; announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted to recommend not approving roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, for the treatment of anemia due to chronic kidney disease (CKD) in adult patients. The Committee based its recommendation on data from a global Phase 3 program encompassing more than 8,000 patients. While the FDA is not required to follow the Committee's vote, the agency considers the Committee's non-binding recommendations when making its decision.

TD Holdings, Inc. (Nasdaq: GLG) 25.6% HIGHER; announced that it has entered into a non-binding letter of intent with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and and Hunan Jinmeike New Material Co., Ltd. and their shareholders to acquire both Jinbochuang and Jinmeike to step into the unmanned logistics and new energy vehicle industry.

American Outdoor Brands (NASDAQ: AOUT) 11.2% LOWER; reported Q4 EPS of $0.09, $0.14 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $64.5 million versus the consensus estimate of $62.03 million. American Outdoor Brands sees FY2022 EPS of $1.00-$1.24. American Outdoor Brands sees FY2022 revenue of $280-295 million.

MoneyGram International (NYSE: MGI) 6.3% HIGHER; rumors it is in talks with private equity firm Advent about a potential acquisition.

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) 6.1% LOWER; discontinued its Phase 3 study of mupadolimab for COVID-19 due to positive trends exhibited by COVID-19 vaccines in lowering serious infection and hospitalizations. The discontinuation is not related to any safety or efficacy issues observed in study patients. The Company will continue to advance the development of mupadolimab in oncology, where it is currently being studied in a Phase 1/1b clinical trial.

Moderna Inc. (NASDAQ: MRNA) 6% HIGHER; will replace Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) in the S&P 500 effective prior to the opening of trading on Wednesday, July 21

fuboTV Inc. (NYSE: FUBO) 5.3% HIGHER; Fubo Gaming, a subsidiary of leading sports-first live TV streaming platform fuboTV Inc. (NYSE: FUBO), and The Cordish Companies announced today the completion of a market access agreement for the forthcoming mobile Fubo Sportsbook in Pennsylvania. Fubo Gamings agreement with The Cordish Companies, owner and operator of Live! Casino & Hotel Philadelphia and Live! Casino Pittsburgh, provides for state-wide mobile access for both sports betting and iGaming. The launch of Fubo Sportsbook in Pennsylvania is subject to obtaining requisite regulatory approvals.

AMC (NYSE: AMC) 5.4% HIGHER; gains pre-open.

Maxar Technologies Ltd (NYSE: MAXR) 4.5% HIGHER; Morgan Stanley initiates coverage with an Overweight rating and a price target of $50.00.

Autoliv (NYSE: ALV) 3.9% LOWER; reported Q2 EPS of $1.20, $0.28 worse than the analyst estimate of $1.48. Revenue for the quarter came in at $2.02 billion versus the consensus estimate of $2.13 billion.

Didi Global (NASDAQ: DIDI) 3.9% LOWER; reports that numerous government regulatory agencies visited the company’s office in China to conduct a review.

Live Nation Entertainment (NYSE: LYV) 3.5% HIGHER; Goldman Sachs initiates coverage with a Buy rating and a price target of $110.00.

Nkarta Inc. (NASDAQ: NKTX) 3.1% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $75.00.

Alpha Pro Tech Ltd. (NYSE: APT) 3% HIGHER; LA County will now require masks indoors regardless of vaccination status, starting July 17.

PlayStudios (NASDAQ: MYPS) 1.9% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $11.00.